WallStreetZenWallStreetZen

NASDAQ: NVAX
Novavax Inc Stock Ownership - Who owns Novavax?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Novavax Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John TrizzinoPresident and COO2025-03-0713,954$8.34
$116.38kSell
James Patrick KellyEVP CFO and Treasurer2025-03-075,904$8.34
$49.24kSell
Elaine OharaEVP Chief Strategy Officer2025-03-0110,969$8.33
$91.37kSell
John C. JacobsPresident and CEO2025-03-0138,451$8.33
$320.30kSell
James Patrick KellyEVP CFO and Treasurer2025-03-0128,337$8.33
$236.05kSell
John TrizzinoPresident and COO2025-03-0123,185$8.33
$193.13kSell
Elaine OharaEVP Chief Strategy Officer2025-03-015,375$8.33
$44.77kSell
Mark J. CaseyEVP Chief Legal Officer2025-03-011,214$8.33
$10.11kSell
John C. JacobsPresident and CEO2025-01-2338,873$9.55
$371.24kSell
Gregg H. AltonDirector2024-12-311,982$8.61
$17.07kBuy

1 of 2

NVAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NVAX insiders and whales buy or sell their stock.

NVAX Shareholders

What type of owners hold Novavax Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc9.50%15,433,212$135.66MInstitution
Blackrock Inc7.85%12,743,155$112.01MInstitution
Shah Capital Management7.09%11,511,780$101.19MInstitution
Cadila Pharmaceuticals Ltd5.85%9,500,000$83.51MInsider
Sanofi4.24%6,880,481$60.48MInstitution
State Street Corp4.20%6,824,251$59.99MInstitution
James B. 1. Tananbaum3.86%6,268,455$55.10MInsider
Sj Strategic Investments LLC2.46%4,001,500$35.17MInsider
D E Shaw Co Inc2.43%3,940,960$34.64MInstitution
Coatue Management LLC2.36%3,836,986$33.73MInstitution

1 of 3

NVAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NVAX62.75%17.11%Net Selling
SYRE71.13%28.87%Net SellingNet Selling
TSHA89.44%10.56%Net BuyingNet Selling
AMLX59.67%40.33%Net SellingNet Selling
NUVB58.49%41.51%Net Buying
View Top Biotech Stocks

Novavax Stock Ownership FAQ

Who owns Novavax?

Novavax (NASDAQ: NVAX) is owned by 62.75% institutional shareholders, 17.11% Novavax insiders, and 20.14% retail investors. Cadila Pharmaceuticals Ltd is the largest individual Novavax shareholder, owning 9.50M shares representing 5.85% of the company. Cadila Pharmaceuticals Ltd's Novavax shares are currently valued at $81.61M.

If you're new to stock investing, here's how to buy Novavax stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.